Aptorum Group skyrockets following launch of infectious disease liquid biopsy diagnostics subsidiary and in-licensing arrangements Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Aptorum Group (APM) up 622% after announcing the launch of Aptorum Innovations, an infectious disease liquid biopsy diagnostics subsidiary and its newly established exclusive in-licensing arrangements with Accelerate Technologies to co-develop novel molecular-based rapid pathogen identification and detection diagnostics technology
- Orgenesis (ORGS) up 16% after announcing the company will acquire all of the outstanding stock of Koligo from its shareholders for $15M in shares of common stock valued at $7.00 per share and an assumption of $1.3M in Koligo's liabilities
- Fluidigm (FLDM) up 7% after
announcing funding for the project with the NIH to expand production capacity and throughput capabilities for COVID-19 testing was increased by approximately $22M, for a total contract value of up to approximately $34M upon the achievement of milestones
UP AFTER EARNINGS -
- AngioDynamics (ANGO) up 8%
- Big Lots (BIG) up 6%
- IHS Markit (INFO) up 1%
- Summit Therapeutics (SMMT) up 1%
DOWN AFTER EARNINGS -
- McCormick (MKC) down 1%
- United Natural Foods (UNFI) up 4%
ALSO LOWER -
- Ironwood (IRWD) down 5% after announcing it will discontinue development of IW-3718
and plans to implement an organizational restructuring, reducing headcount by approximately 100 full-time employees, or nearly 35% of the current workforce
- Nikola (NKLA) down 2% after CNBC reported two women have filed sexual assault allegations with Utah authorities against company founder Trevor Milton, accusing him of sexual abuse
- Host Hotels (HST) down 2% after BofA analyst Shaun Kelley downgraded shares to Underperform from Neutral with a price target of $12.00, down from $12.50
Symbols:
APM ORGS FLDM ANGO BIG INFO SMMT MKC UNFI IRWD NKLA HST Keywords: Fly Intel, Wall Street, Top Stories, Stocks